Genetic characterisation of the emerging invasive neisseria meningitidis serogroup y in sweden, 2000 to 2010

Eurosurveillance

Volumn 16, Issue 23, 2011, Pages

  Thulin Hedberg, S ^a   Toros B ^a   Fredlund, H ^a   Olcen P ^a   Molling P ^a  

^a ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

SULFADIAZINE;

ADULT; AGED; ALLELE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL GENETICS; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CONTROLLED STUDY; FETA GENE; FHBP GENE; GENE SEQUENCE; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MENINGOCOCCOSIS; MOLECULAR CLONING; MORTALITY; MULTILOCUS SEQUENCE TYPING; NEISSERIA MENINGITIDIS; NONHUMAN; PENA GENE; PORA GENE; PORB GENE; SWEDEN;

EID: 79959480972     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Stephens DS, Greenwood B, Brandtzaeg P. Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet. 2007;369(9580):2196-2210.
2. Caugant DA. Genetics and evolution of Neisseria meningitidis: importance for the epidemiology of meningococcal disease. Infect Genet Evol. 2008;8(5):558-565.
3. Harrison LH, Trotter CL, Ramsay ME. Global epidemiology of meningococcal disease. Vaccine. 2009;27 Suppl 2:B51-B63.
4. Rosenstein NE, Perkins BA, Stephens DS, Lefkowitz L, Cartter ML, Danila R, et al. The changing epidemiology of meningococcal disease in the United States, 1992-1996. J Infect Dis. 1999;180(6):1894-1901.
5. Centers for Disease Control and Prevention (CDC). Active bacterial core Surveillance (ABCs) report. Emerging Infections Program Network. Neisseria meningitidis, 2009. Oct2010 File - 17 Nov 2010. Available from: http://www.cdc.gov/abcs/reports-findings/survreports/mening09.pdf
6. Tsang RS, Henderson AM, Cameron ML, Tyler SD, Tyson S, Law DK, et al. Genetic and antigenic analysis of invasive serogroup Y Neisseria meningitidis isolates collected from 1999 to 2003 in Canada. J Clin Microbiol. 2007;45(6):1753-1758.
7. Inés Agudelo C, Sanabria OM, Ovalle MV. Serogroup Y meningococcal disease, Colombia. Emerg Infect Dis. 2008;14(6):990-991.
8. The European Meningococcal Disease Society (EMGM). 11th EMGM meeting, 18-20 May 2011, Ljubljana Slovenia. Poster abstracts P035, 037-040.
9. Jolley KA, Brehony C, Maiden MC. Molecular typing of meningococci: recommendations for target choice and nomenclature. FEMS Microbiol Rev. 2007;31(1):89-96.
10. European Centre for Disease Prevention and Control (ECDC). Case definition. 2008 EU Case Definition (2008/426/EC) for meningococcal disease, invasive. Stockholm: ECDC. Available from: http://www.ecdc.europa.eu/EN/ACTIVITIES/ SURVEILLANCE/EU_IBD/Pages/Case_definition.aspx
11. Olcén P, Danielsson D, Kjellander J. The use of protein A-containing staphylococci sensitized with anti-meningococcal antibodies for grouping Neisseria meningitidis and demonstration of meningococcal antigen in cerebrospinal fluid. Acta Pathol Microbiol Scand B. 1975;83(4):387-396.
12. Mölling P, Jacobsson S, Backman A, Olcén P. Direct and rapid identification and genogrouping of meningococci and porA amplification by LightCycler PCR. J Clin Microbiol. 2002;40(12):4531-4535.
13. Tettelin H, Saunders NJ, Heidelberg J, Jeffries AC, Nelson KE, Eisen JA, et al. Complete genome sequence of Neisseria meningitidis serogroup B strain MC58. Science. 2000;287(5459):1809-1815.
14. Primers used for MLST of Neisseria. Neisseria Multi Locus Sequence Typing website (http://pubmlst.org/ neisseria/) developed by Keith Jolley and sited at the University of Oxford. [Accessed 4 Mar 2011]. Available from: http://pubmlst.org/neisseria/info/primers.shtml
15. Taha MK, Vazquez JA, Hong E, Bennett DE, Bertrand S, Bukovski S, et al. Target gene sequencing to characterize the penicillin G susceptibility of Neisseria meningitidis. Antimicrob Agents Chemother. 2007;51(8):2784-2792.
16. Thulin S, Olcen P, Fredlund H, Unemo M. Total variation in the penA gene of Neisseria meningitidis: correlation between susceptibility to beta-lactam antibiotics and penA gene heterogeneity. Antimicrob Agents Chemother. 2006;50(10):3317-3324.
17. Urwin R. Nucelotide sequencing of antigen genes of Neisseria meningitidis. In: Pollard AJ, Maiden MCJ, editors. Meningococcal disease. New Jersey: Humana Press; 2001. p. 165.
18. Jacobsson S, Thulin S, Mölling P, Unemo M, Comanducci M, Rappuoli R, et al. Sequence constancies and variations in genes encoding three new meningococcal vaccine candidate antigens. Vaccine. 2006;24(12):2161-2168.
19. Brehony C, Wilson DJ, Maiden MC. Variation of the factor H-binding protein of Neisseria meningitidis. Microbiology. 2009;155(Pt 12):4155-4169.
20. Sequence query. Neisseria Multi Locus Sequence Typing website (http://pubmlst.org/ neisseria/) developed by Keith Jolley and sited at the University of Oxford. [Accessed 4 Mar 2011]. Available from: http://pubmlst.org/perl/bigsdb/bigsdb.pl?db=pubmlst_neisseria_seqdef&page=sequenceQuery
21. Hunter PR, Gaston MA. Numerical index of the discriminatory ability of typing systems: an application of Simpson's index of diversity. J Clin Microbiol. 1988;26(11):2465-2466.
22. Grundmann H, Hori S, Tanner G. Determining confidence intervals when measuring genetic diversity and the discriminatory abilities of typing methods for microorganisms. J Clin Microbiol. 2001;39(11):4190-4192.
23. MLST data analysis. Neisseria Multi Locus Sequence Typing website (http://pubmlst.org/ neisseria/) developed by Keith Jolley and sited at the University of Oxford. [Accessed 9 Mar 2011]. Available from: http://pubmlst.org/analysis/
24. McEllistrem MC, Kolano JA, Pass MA, Caugant DA, Mendelsohn AB, Fonseca Pacheco AG, et al. Correlating epidemiologic trends with the genotypes causing meningococcal disease, Maryland. Emerg Infect Dis. 2004;10(3):451-456.
25. Harrison LH, Jolley KA, Shutt KA, Marsh JW, O'Leary M, Sanza LT, et al. Antigenic shift and increased incidence of meningococcal disease. J Infect Dis. 2006;193(9):1266-1274.
26. Jacobsson S, Olcén P, Löfdahl M, Fredlund H, Mölling P. Characteristics of Neisseria meningitidis isolates causing fatal disease. Scand J Infect Dis. 2008;40(9):734-744.
27. Bidmos FA, Neal KR, Oldfield NJ, Turner DP, Ala'Aldeen DA, Bayliss CD. Persistence, replacement, and rapid clonal expansion of meningococcal carriage isolates in a 2008 university student cohort. J Clin Microbiol. 2011;49(2):506-512.
28. Yazdankhah SP, Kriz P, Tzanakaki G, Kremastinou J, Kalmusova J, Musilek M, et al. Distribution of serogroups and genotypes among disease-associated and carried isolates of Neisseria meningitidis from the Czech Republic, Greece, and Norway. J Clin Microbiol. 2004;42(11):5146-5153.
29. Glitza IC, Ehrhard I, Müller-Pebody B, Reintjes R, Breuer T, Ammon A, et al. Longitudinal study of meningococcal carrier rates in teenagers. Int J Hyg Environ Health. 2008;211(3-4):263-272.
30. Claus H, Maiden MC, Wilson DJ, McCarthy ND, Jolley KA, Urwin R, et al. Genetic analysis of meningococci carried by children and young adults. J Infect Dis. 2005;191(8):1263-1271.